Cargando…
B-cell Activating Factor Polymorphisms in Rheumatoid Arthritis-Associated Atherosclerosis
Rheumatoid Arthritis (RA) is a common chronic inflammatory disorder affecting 0,5–1% of the population, characterised by intense cellular activation and inflammation in the affected joints ultimately leading to bone and cartilage destruction. Cardiovascular disease is the leading cause of death amon...
Autores principales: | Kintrilis, Nikolaos, Nezos, Adrianos, Theodorou, Evangelos, Koutsilieris, Michalis, Mavragani, Clio P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Mediterranean Journal of Rheumatology (MJR)
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369273/ https://www.ncbi.nlm.nih.gov/pubmed/34447918 http://dx.doi.org/10.31138/mjr.32.2.179 |
Ejemplares similares
-
The Role of Novel Autoantibodies in the Diagnostic Approach and Prognosis of Patients with Raynaud’s Phenomenon
por: Koulouri, Vasiliki, et al.
Publicado: (2020) -
Osteoprotegerin and MTHFR gene variations in rheumatoid arthritis: association with disease susceptibility and markers of subclinical atherosclerosis
por: Arida, Aikaterini, et al.
Publicado: (2022) -
Milk Fat Globule Epidermal Growth Factor 8 (MFGE8) Gene Variants in Rheumatoid Arthritis and Sjögren’s Syndrome
por: Skarlis, Charalampos, et al.
Publicado: (2022) -
Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related Lymphomagenesis
por: Nezos, Adrianos, et al.
Publicado: (2015) -
+3179G/A Insulin-Like Growth Factor-1 Receptor Polymorphism: A Novel Susceptibility Contributor in Anti-Ro/SSA Positive Patients with Sjögren’s Syndrome: Potential Clinical and Pathogenetic Implications
por: Skarlis, Charalampos, et al.
Publicado: (2021)